Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life
Open Access
- 26 July 2023
- journal article
- research article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 34 (8) , 1648-1657
Abstract
Introduction: Obesity is a well‐known risk factor for atrial fibrillation (AF). We aim to evaluate the effect of baseline obesity on procedural complications, AF recurrence, and symptoms following catheter ablation (CA).Methods: All consecutive patients undergoing AF ablation (2013–2021) at our center were enrolled in a prospective registry. The study included all consecutive patients with available data on body mass index (BMI). Primary endpoint was AF recurrence based on electrocardiographic documentation. Patients were categorized into five groups according to their baseline BMI. Patients survey at baseline and at follow‐up were used to calculate AF symptom severity score (AFSS) as well as AF burden (mean of AF duration score and AF frequency score; scale 0: no AF to 10: continuous and 9 frequencies/durations in between). Patients were scheduled for follow‐up visits with 12‐lead electrocardiogram at 3, 6, and 12 months after ablation, and every 6 months thereafter.Results: A total of 5841 patients were included (17% normal weight, 34% overweight, 27% Class I, 13% Class II, and 9% Class III obesity). Major procedural complications were low (1.5%) among all BMI subgroups. At 3 years AF recurrence was the highest in Class III obesity patients (48%) followed by Class II (43%), whereas Class I, normal, and overweight had similar results with lower recurrence (35%). In multivariable analyses, Class III obesity (BMI ≥ 40) was independently associated with increased risk for AF recurrence (hazard ratio, 1.30; confidence interval, 1.06–1.60; p = .01), whereas other groups had similar risk in comparison to normal weight. Baseline AFSS was lowest in normal weight, and highest in Obesity‐III, median (interquartile range) 10 (5–16) versus 15 (10–21). In all groups, CA resulted in a significant improvement in their AFSS with a similar magnitude among the groups. At follow‐up, AF burden was minimal and did not differ significantly between the groups.Conclusion: AF ablation is safe with a low complication rate across all BMI groups. Morbid obesity (BMI ≥ 40) was significantly associated with reduced AF ablation success. However, ablation resulted in improvement in QoL including reduction of the AFSS, and AF burden regardless of BMI.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation CohortJACC, 2015
- Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of AblationJACC, 2014
- The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled AnalysisPLOS ONE, 2013
- Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablationHeart Rhythm, 2011
- The global obesity pandemic: shaped by global drivers and local environmentsThe Lancet, 2011
- Body mass index, waist circumference and waist–hip ratio: which is the better discriminator of cardiovascular disease mortality risk? Evidence from an individual‐participant meta‐analysis of 82 864 participants from nine cohort studiesObesity Reviews, 2011
- Body Mass Index, Obstructive Sleep Apnea, and Outcomes of Catheter Ablation of Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2008
- Catheter Ablation for Atrial Fibrillation in Patients With ObesityCirculation, 2008
- Pulmonary vein antrum isolationHeart Rhythm, 2007
- Risk of New-Onset Atrial Fibrillation in Relation to Body Mass IndexArchives of internal medicine (1960), 2006